abstract |
The present invention is represented by the formula: (Wherein R 1 , R 3 , L 1 , L 2 , G 1 , G 2 , A and m are as defined in the specification) and optical isomers, racemates and tautomers thereof As well as methods for its preparation, pharmaceutical compositions containing it and its use in therapy. The compound is an inhibitor of microsomal prostaglandin E synthase-1. |